New Delhi: The US arm of Sun Pharmaceutical Industries Ltd has recalled more than 5,200 units of testosterone cypionate injections from the American market, the latest enforcement report of the United States Food and Drug Administration (US FDA) has said. Sun Pharmaceutical Industries Inc. is recalling 5,215 units of 10 ml vials of testosterone cypionate injections in the strength of 200 mg/ml, on account of “presence of particulate matter: organic and inorganic compounds detected in vials of product", the report said.
The injections were manufactured by Sun Pharma at its Halol plant. Testosterone
According to the USFDA report, the ongoing voluntary nationwide recall is a Class II recall, initiated in a situation “in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote".
The injections are indicated for replacement therapy in the male in conditions associated with symptoms of deficiency or absence of endogenous testosterone.
PTI contributed to this story.
Download the Mint app and read premium stories
Log in to our website to save your bookmarks. It'll just take a moment.
You are just one step away from creating your watchlist!
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.
Your session has expired, please login again.
You are now subscribed to our newsletters. In case you can’t find any email from our side, please check the spam folder.
Anti Estrogen Steroids This is a subscriber only feature Subscribe Now to get daily updates on WhatsApp